Our company news

We are working on the following new projects: We were awarded a contract for medical writing services by a global pharmaceutical company.

We are working on the following new projects: We are starting a phase I Pertuzumab trial.

We are working on the following new projects: Smooth started synopsis preparation services with Benzidamine+Cetylpyridinium chloride.

We are working on the following new projects: A phase 3 clinical trial of Nimesulide Gel 2% was awarded to SDD.

We are working on the following new projects: Semaglutide trial was awarded to SDD.

We are working on the following new projects: • We received a contract for a phase I study with Pembrolizumab.

We are working on the following new projects: • A contract for a phase III study with Aflibercept was signed.

January We are working on the following new projects: • We have successfully passed quality control of a global company and we are finalizing a contract for data management activities in observational programs.

We are working on the following new projects: • We signed a contract for a phase III trial in patients with nasopharyngitis.

We are working on the following new projects: • We won a bidding for an adalimumab trial, phase I.

October We are working on the following new projects: • We signed a contract for medical writing activities for a phase III trial with glucosamine + chondroitin sulfate.

We are working on the following new projects: • We signed a contract for medical writing activities for a BE trial with our long-term Client.

August We are working on the following new projects: • We were awarded with medical writing activities for bioequivalence trials with Triptorelin.

We are working on the following new projects: • We were awarded with 6 bioequivalence trials with Gliclazide, Liraglutide, Vildagliptin, Dolutegravir and Empagliflozin 10 mg and 25 mg.

We are working on the following new projects: • We signed a contract for a bioequivalence trial with Edoxaban.